Sort by
Refine Your Search
-
through cutting-edge research. Join City of Hope as an Administrative Program Coordinator and play a pivotal role in driving the success of a dynamic department. This position performs a variety of
-
: Contribute to innovative approaches in predicting, preventing, and curing diseases, shaping the future of medicine through cutting-edge research. The Microbiome Program is seeking a highly motivated Research
-
Join the forefront of groundbreaking research at City of Hope , where we're changing lives and making a real difference in the fight against cancer, diabetes, and other life-threatening illnesses. Our dedicated and compassionate faculty and staff are driven by a common mission: Contribute to...
-
, shaping the future of medicine through cutting-edge research. A Postdoctoral Fellowship opportunity is available immediately in the Cutaneous Lymphoma Program at City of Hope. Dr. Christiane Querfeld
-
through cutting-edge research. A postdoctoral research fellow position in the department of Computational and Quantitative Medicine. For more information about Dr. Vaidehi’s lab, please visit here. As a
-
through cutting-edge research. Join Dr. Marcel van den Brink’s multidisciplinary team to explore innovative ways to decipher the molecular mechanisms by which the microbiome contributes to the biology of
-
, shaping the future of medicine through cutting-edge research. A Postdoctoral Research Fellow position is open under Dr. Nagarajan Vaidehi within the department of Computational and Quantitative Medicine
-
, shaping the future of medicine through cutting-edge research. We’re looking for a motivated and compassionate Exercise Physiologist I to join our Exercise Oncology Program. In this role, you’ll be
-
through cutting-edge research. The Nath lab is seeking applicants for a postdoctoral position in computational cancer biology. Our lab aims to enhance cancer treatment outcomes through two main research
-
the biological mechanisms linking cardiovascular diseases with cancer and cancer therapies. She uses human-induced pluripotent stem cells (iPSCs), patient-derived samples, genomics, and computational biology to